Menu

ProQR Therapeutics N.V. PRQR

Full chart Compare
Set alert

Price alert · PRQR

All alert types
1.38 USD +0.03 (+2.22%)

At closeNov 9, 2026, 4:00 PM EST

1.40 +0.02 +1.45%

After hours · Nov 9, 4:00 PM ET

1.36 Day range 1.41
1.20 52-week range 2.49
YTD
-31.68%
1 year
-37.84%

Revenue & Expenses

Other Income → Expenses: $2.57MExpenses → Selling, General & Admin: $15.06MExpenses → Research & Development: $44.73MExpenses → Interest Expense: $1.29MExpenses → Income Tax: $19.00KGross Profit → Expenses: $16.35MRevenue → Gross Profit: $16.35MNet Loss → Expenses: $42.18MOther Income$2.57MGross Profit$16.35MNet Loss$42.18MExpenses$61.10MSelling, General & Admin$15.06MResearch & Development$44.73MInterest Expense$1.29MIncome Tax$19.00KRevenue$16.35M

Latest period ending Dec 31, 2025 · select a line to chart its full history

PRQR annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
16.35M19.55M9.53M4.36M2.38M
16.35M19.55M9.53M4.36M2.38M
-43.45M-30.47M-31.86M-65.16M-57.21M
-42.18M-27.76M-28.12M-64.42M-60.74M
-0.40-0.32-0.35-0.90-0.95
PRQR annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
92.41M149.41M118.92M94.78M187.52M
112.76M167.96M137.88M171.32M209.58M
63.38M79.40M96.49M104.64M96.35M
15.96M17.22M19.73M21.97M60.37M
49.37M88.56M41.39M67.06M113.83M
PRQR annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-54.59M-39.07M19.67M-64.76M-26.01M
-1.02M-4.07M4.28M-702.00K-425.00K
-1.84M70.28M-2.27M-30.89M136.83M
-1.02M-1.42M6.63M-702.00K-425.00K
-55.65M29.81M23.55M-100.10M110.39M